There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Alterations in glutamatergic neurotransmission may be fundamental to the pathophysiology
of schizophrenia, and the glutamatergic system is a target for novel therapeutic interventions
in the disorder.